Your session is about to expire
← Back to Search
Robotics
Rehabilitation Robot for Stroke Recovery
N/A
Recruiting
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Stroke secondary to subarachnoid hemorrhage or posterior circulation stroke
Significant musculoskeletal problems
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-overground, morning walk intervention, and post-overground of assessment in one day and will be recorded continuously for 20-30minutes
Awards & highlights
Summary
This trial aims to test a robot called Morning Walk® to help adults recover from stroke by improving their walking patterns. The robot has been approved by the FDA for safety and effectiveness.
Who is the study for?
This trial is for adults who have an uneven walking pattern due to a stroke (hemiparesis) and also includes healthy individuals. Participants should be able to follow the study procedures. People with other medical conditions that could interfere with their participation or those who can't use the Morning Walk® robot are excluded.
What is being tested?
The study tests how well the Morning Walk® rehabilitation robot helps improve symmetrical walking in people affected by stroke compared to healthy individuals. The device has been cleared by the FDA, ensuring it's safe and potentially effective for this purpose.
What are the potential side effects?
Since this trial involves a physical therapy device rather than medication, side effects may include muscle soreness, fatigue, or discomfort from using the equipment.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I had a stroke caused by bleeding in the brain or in the back part of my brain.
Select...
I have major issues with my muscles or bones.
Select...
I am not in a coma.
Select...
I cannot follow 3-step commands.
Select...
I have had an amputation.
Select...
I have diabetes with severe complications like foot ulcers.
Select...
My neurological condition is getting worse.
Select...
I have unstable chest pain.
Select...
I have been diagnosed with heart failure.
Select...
I have peripheral vascular disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-overground, morning walk intervention, and post-overground of assessment in one day and will be recorded continuously for 20-30minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-overground, morning walk intervention, and post-overground of assessment in one day and will be recorded continuously for 20-30minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Muscle Activity in the lower extremities
Spatiotemporal Patterns of Walking, Parameters
Spatiotemporal Patterns of Walking, Speeds
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Morning Walk Training for StrokeExperimental Treatment1 Intervention
Group II: Morning Walk Training for HealthyActive Control1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Medical Branch, GalvestonLead Sponsor
249 Previous Clinical Trials
56,600 Total Patients Enrolled
4 Trials studying Stroke
122 Patients Enrolled for Stroke
Share this study with friends
Copy Link
Messenger